DNA repair pathway choice mediates somatic cell reprogramming
DNA修复途径选择介导体细胞重编程
基本信息
- 批准号:10249291
- 负责人:
- 金额:$ 46.71万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-09-01 至 2024-05-31
- 项目状态:已结题
- 来源:
- 关键词:AffectAneuploidyBRCA1 geneBasic ScienceBiological AssayCell CycleCell Cycle ProgressionCell LineCell TherapyCellsCharacteristicsCompetenceDNADNA DamageDNA Double Strand BreakDNA RepairDNA Repair PathwayDNA biosynthesisDNA replication forkDataDevelopmentDouble Strand Break RepairFrequenciesG2 PhaseGenerationsGenetic TranscriptionGenomeGenome StabilityGenomic InstabilityGenomicsImpairmentLaboratoriesLeadLocationMapsMediatingMitosisMolecularMusMutationNonhomologous DNA End JoiningOpticsPathway interactionsPluripotent Stem CellsRepetitive SequenceResearchRoleS PhaseSignal TransductionSiteSomatic CellStructureSystemTP53 geneTechniquescell typegenome integrityhomologous recombinationimprovedinduced pluripotent stem cellmutantnext generation sequencingnuclear transferoverexpressionp53-binding protein 1repairedsenescencesomatic cell nuclear transferstem cellswhole genome
项目摘要
Project Summary
Reprogramming is the conversion of a somatic cell to a pluripotent stem cell. This technique is now routinely
used in laboratories around the world, but the vast majority of reprogrammed stem cell lines are not
developmentally fully competent, compromising their utility in research and therapy. Reprogramming induces
DNA damage, which can have lasting consequences on the quality of the resulting cells. Our studies have
shown that DNA damage during reprogramming is induced by abnormalities in DNA replication. However, the
cause of DNA damage, the mechanisms of repair, and the developmental consequences of the damage are
not well understood. The strength of this proposal is that with the experimental systems used, we are able to
identify the specific type of damage induced by reprogramming, and the molecular mechanisms required for
repair: we are able to distinguish the role of double strand break HR from the role of stalled replication fork
stability. We are also able to distinguish the effect of genome instability on reprogramming efficiency from
incomplete transcriptional transitions. We are able to map the sites in the genome with reprogramming-induced
damage, and we are able to identify pathways that can be used to increase genome stability and potentially
improve developmental competence of reprogrammed stem cells. These studies will provide a mechanistic
understanding how genome instability inhibits the induced transition between different cellular states.
项目总结
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Dieter Meinrad Egli其他文献
Dieter Meinrad Egli的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Dieter Meinrad Egli', 18)}}的其他基金
Enhancer-based Immune and Beta Cell Dysregulation Underlying T1D Risk
基于增强剂的免疫和 β 细胞失调是 T1D 风险的基础
- 批准号:
10442605 - 财政年份:2020
- 资助金额:
$ 46.71万 - 项目类别:
DNA repair pathway choice mediates somatic cell reprogramming
DNA修复途径选择介导体细胞重编程
- 批准号:
9973944 - 财政年份:2020
- 资助金额:
$ 46.71万 - 项目类别:
DNA repair pathway choice mediates somatic cell reprogramming
DNA修复途径选择介导体细胞重编程
- 批准号:
10618907 - 财政年份:2020
- 资助金额:
$ 46.71万 - 项目类别:
Enhancer-based Immune and Beta Cell Dysregulation Underlying T1D Risk
基于增强剂的免疫和 β 细胞失调是 T1D 风险的基础
- 批准号:
10671012 - 财政年份:2020
- 资助金额:
$ 46.71万 - 项目类别:
Enhancer-based Immune and Beta Cell Dysregulation Underlying T1D Risk
基于增强剂的免疫和 β 细胞失调是 T1D 风险的基础
- 批准号:
10263319 - 财政年份:2020
- 资助金额:
$ 46.71万 - 项目类别:
DNA repair pathway choice mediates somatic cell reprogramming
DNA修复途径选择介导体细胞重编程
- 批准号:
10413221 - 财政年份:2020
- 资助金额:
$ 46.71万 - 项目类别:
Novel approaches to map DNA replication traffic in a genome-wide scale
在全基因组范围内绘制 DNA 复制流量图的新方法
- 批准号:
9923689 - 财政年份:2019
- 资助金额:
$ 46.71万 - 项目类别:
相似海外基金
Elucidating the effects of extra chromosome elimination in mosaic aneuploidy syndromes: Pallister-Killian syndrome as a model
阐明额外染色体消除对嵌合非整倍体综合征的影响:以 Pallister-Killian 综合征为模型
- 批准号:
10887038 - 财政年份:2023
- 资助金额:
$ 46.71万 - 项目类别:
Characterization of aneuploidy, cell fate and mosaicism in early development
早期发育中非整倍性、细胞命运和嵌合体的表征
- 批准号:
10877239 - 财政年份:2023
- 资助金额:
$ 46.71万 - 项目类别:
The impact of aneuploidy on early human development
非整倍体对人类早期发育的影响
- 批准号:
MR/X007979/1 - 财政年份:2023
- 资助金额:
$ 46.71万 - 项目类别:
Research Grant
Understanding how aneuploidy disrupts quiescence in the model eukaryote Saccharomyces cerevisiae
了解非整倍体如何破坏模型真核生物酿酒酵母的静止状态
- 批准号:
10735074 - 财政年份:2023
- 资助金额:
$ 46.71万 - 项目类别:
Preventing Age-Associated Oocyte Aneuploidy: Mechanisms Behind the Drosophila melanogaster Centromere Effect
预防与年龄相关的卵母细胞非整倍性:果蝇着丝粒效应背后的机制
- 批准号:
10538074 - 财政年份:2022
- 资助金额:
$ 46.71万 - 项目类别:
Functional evaluation of kinesin gene variants associated with female subfertility and egg aneuploidy.
与女性生育力低下和卵子非整倍性相关的驱动蛋白基因变异的功能评估。
- 批准号:
10537275 - 财政年份:2022
- 资助金额:
$ 46.71万 - 项目类别:
Using CRISPR screening to uncover aneuploidy-specific genetic dependencies
使用 CRISPR 筛选揭示非整倍体特异性遗传依赖性
- 批准号:
10661533 - 财政年份:2022
- 资助金额:
$ 46.71万 - 项目类别:
Comparative Analysis of Aneuploidy and Cellular Fragmentation Dynamics in Mammalian Embryos
哺乳动物胚胎非整倍性和细胞破碎动力学的比较分析
- 批准号:
10366610 - 财政年份:2022
- 资助金额:
$ 46.71万 - 项目类别:
FASEB SRC: The Consequences of Aneuploidy: Honoring the Contributions of Angelika Amon
FASEB SRC:非整倍体的后果:纪念 Angelika Amon 的贡献
- 批准号:
10467260 - 财政年份:2022
- 资助金额:
$ 46.71万 - 项目类别:














{{item.name}}会员




